California Resources Corporation. CRC 2.15 0.65 (40.97%). NYSEMkt Updated Jun 5, 2020 11:58 PM It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland. Find the latest Cerecor Inc. (CERC) stock quote, history, news and other vital information to help you with your stock trading and investing. Cerecor, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company has a portfolio of clinical and preclinical compounds, such as CERC-301, CERC-501, and CERC-406. NASDAQ Updated Jun 8, 2020 11:52 PM. 5,186 Watchers. Watch
2 Apr 2019 The generic tariffs for power purchase from renewable energy sources, i.e. biogas, small hydro projects, biomass with Rankine cycle projects Elements for a redefinition of narratology research: Analysis of the anti- Aristotelian model of Nietzsche's Birth of Tragedy. Antonino Sorci 1, 2. Détails. 1 CERC -
NASDAQ Updated Jun 8, 2020 11:52 PM. 5,186 Watchers. Watch Geron Corporation. GERN 1.68 0.14 (9.09%). NASDAQ Updated Jun 8, 2020 8:00 PM Public hearing on draft Central Electricity Regulatory Commission (Terms and Conditions for Tariff determination from Renewable Energy Sources) Regulations, 2020 will be held on 19th June 2020 Draft Central Electricity Regulatory Commission (Terms and Conditions of Tariff) (Second Amendment) Regulations, 2020. Description: Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. Trend Table for CERC - Cerecor Inc. CERC Chart by TradingView StockTwits Facebook Twitter Real Estate Sign Post Installation SwingTradeBot Australia (ASX)
Cerecor Inc. Common Stock (CERC) Analyst Research | Nasdaq Based on analysts offering 12 month price targets for CERC in the last 3 months. The average price target is $ 10 with a high estimate of $ 10 and a low estimate of $ 10 . Cerecor Inc - CERC - Stock Price & News | The Motley Fool cerc $2.31 $0.02 0.9% Price as of May 20, 2020, 11:38 a.m. EDT View Interactive CERC Charts
It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland. Find the latest Cerecor Inc. (CERC) stock quote, history, news and other vital information to help you with your stock trading and investing. Cerecor, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company has a portfolio of clinical and preclinical compounds, such as CERC-301, CERC-501, and CERC-406. NASDAQ Updated Jun 8, 2020 11:52 PM. 5,186 Watchers. Watch Geron Corporation. GERN 1.68 0.14 (9.09%). NASDAQ Updated Jun 8, 2020 8:00 PM Public hearing on draft Central Electricity Regulatory Commission (Terms and Conditions for Tariff determination from Renewable Energy Sources) Regulations, 2020 will be held on 19th June 2020 Draft Central Electricity Regulatory Commission (Terms and Conditions of Tariff) (Second Amendment) Regulations, 2020.